Roche's Rituxan wins rare-disorder indications; SciClone buys China's NovaMed for up to $104M;

@FiercePharma: U.S. drug spending grows at anemic 2.3% in 2010. News | Follow @FiercePharma

> Roche's Rituxan drug won FDA approval as a treatment for Wegener's granulomatosis and microscopic polyangilitis, two rare disorders that cause blood vessel inflammation. News

> SciClone Pharmaceuticals bought the Chinese drugmaker NovaMed Pharmaceuticals for $24.7 million in cash, plus $37.1 million in common stock, with an additional $43 million cash payable if financial targets are met. Item

> FDA has approved Taro Pharmaceutical's Imiquimod cream, a generic version of Graceway Pharmaceuticals' Aldara treatment for actinic keratosis and external genital warts. Article

> Sagent Pharmaceuticals increased the size of its initial public offering to 5.75 million shares of common stock at a price of $16 per share. Report

> Biogen Idec won a positive recommendation from European regulators for a new self-administered form of its Avonex multiple sclerosis treatment, dubbed the "Avonex Pen." Story

> A series of new deals with licensees in a wide range of emerging markets has set the stage for expanded sales of Teijin Pharma's novel gout drug febuxostat. Report

> An Ohio woman has sued AstraZeneca, alleging that she suffered bone deterioration and broken bones because of hidden risks with the drugmaker's acid reflux treatment Nexium. Gibson Law Firm release

> A UK chemist chain is now offering Viagra to customers without the need for a prescription. News

> The Czech Republic's State Institute for Drug Control approved the cannabis-derived medicine Sativex, produced by UK drugmaker GW Pharmaceuticals, as a treatment for symptoms of multiple sclerosis. Report

Biotech News

 @FierceBiotech: Novartis yanks European app for Cox-2 pain drug. News | Follow @FierceBiotech

 @JohnCFierce: Novartis' Ph3 success advances blockbuster COPD program. Item | Follow @JohnCFierce

> NicOx shares pummeled after EU panel rejects naproxcinod. Story 

> Gilead inks pact on experimental RSV treatment. News 

> Bluebird's gene therapy song attracts $30M venture round. Article 

> Sangart raises $50M to fund critical Ph2b ischemia study. Item 

Drug Delivery News

> EU gives consortium $1.6M for ultrasound-triggered drug delivery. News

> Novartis has big plans for SmartPills. Report

> Polysaccharides offer a sweet way to deliver arthritis meds. Story

> Injectable gel promises on-demand, long-term delivery of arthritis medication. Item

>  DNA origami unfolding for drug delivery. Report 

> Simple electrical on/off switch controls drug-delivering membrane. Article 

Medical Device News

> Roche gets FDA OK for HPV test. Story

> St. Jude's Q1 results beat expectations. Item 

> Stryker sees profit slip as sales rise. News 

> Neoprobe's largest investor to drop proxy fight threat. Article 

> Medtronic introduces new product for drawing bone marrow. Story

> Anulex sees layoffs after FDA warning letter. Report

And Finally... A new product, dubbed "Viagra for condoms," is nearing regulatory approval and could be on sale in Europe by the end of the year. News

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.